Spruce Biosciences

Spruce Biosciences: Spruce Biosciences is a clinical-stage biotechnology company focused on developing and commercializing novel therapies for rare endocrine disorders. The company’s lead product candidate, tildacerfont, is an investigational oral drug that is being evaluated in studies for the treatment of congenital adrenal hyperplasia (CAH). The company also plans to evaluate tildacerfont in other diseases impacted by elevated ACTH or adrenal androgens.
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Metabolic Disorders, Rare Disease
Public, USA
Market Cap
100MM - 500MM
1700 Montgomery Street
Suite 212
San Francisco, CA 94111
United States

Company Participants at Summer 2020 NYC Private Company Showcase

  • Richard King, Chief Executive Officer
  • Samir Gharib, Chief Financial Officer

Top 10 Holders of Spruce Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Novo Holdings A/S 21.41 4,989,336 47.65 13F 3/31/21
Omega Fund Management LLC 9.27 2,161,022 20.64 13F 3/31/21
Abingworth LLP 7.69 1,792,518 17.12 13F 3/31/21
Citadel LP 7.31 1,702,805 16.26 13F 3/31/21
Citadel Advisors LLC 7.35 1,701,787 16.25 Stakes 10/14/20
Rock Springs Capital Management LP 6.78 1,579,301 15.08 13F 3/31/21
Deerfield Management Company LP 6.09 1,419,651 13.56 Stakes 5/5/21
Aisling Capital Management LP 5.17 1,205,511 11.51 13F 3/31/21
Fidelity Management & Research Co. LLC 5.13 1,195,073 11.41 13F 3/31/21
Sio Capital Management LLC 3.49 812,884 7.76 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.